PAUSE Perioperative DOAC Management clinical trials

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

This study compares two ways to manage blood thinners (DOACs) before surgery for people with atrial fibrillation or a history of blood clots. It aims to find the safest method for people having surgery with a high risk of bleeding.